Out-licensing: Cardiovascular/Vascular

Up-to-date access to technology licensing opportunities worldwide.

Out-licensing
Browse

Licensing opportunities

Displaying 1..10 of 41 - per page Next page
Order by

1,2,4-benzothiadiazine derivatives useful for the treatment of endocrinological system diseases such as hyperinsulinaemia and diabetes. More

Genes for Niemann-Pick Type C Disease

This invention provides the human gene for Niemann-Pick Type C disease and the nucleic acid sequences corresponding to the human gene for Niemann-Pick Type C disease. More

Proteolysis-resistant human VEGF for wound healing

Wound healing, VEGF, proteolytic-resistant, angiogenesis More

Vascular Clip and Devices for Sutureless Anastomosis and Bypasses (08-31_09-09)

Novel Surgical Clips for Vascular Bypass and Tissue Grafts for Vascular surgery, vascular grafts, sutureless anastomosis and bypass surgery More

Generic version of an ultra short acting beta blocker: Esmolol 2500 mg/10 ml ampoule

Ultrashort acting beta blocker Esmolol for use in anesthesia, intensive care, cardiology and internal medicine. More

Biomarkers For the Early Detection of Pre-eclampsia

Western inventors have identified a group of 12 differentially expressed proteins in Preeclampsia (PE) patients using a state-of-art proteomics based approach. More

A2 Adenosine Receptor Agonists

Compositions and methods of use of A2 adenosine receptor (AR) agonists for treating conditions modulated by A2A and A2B ARs including myocardial ischemia, reperfusion injury, cystic fibrosis, erectile dysfunction, inflammation, restenosis and septic shock More

Vessel Delineation in Magnetic Resonance Angiographic Images

Algorithms and computer-implemented methods for tracking the paths of vessels in magnetic resonance angiography More

ARH3, a Therapeutic Target for Cancer, Ischemia, and Inflammation

A novel PARG-like enzyme, ARH3, that appears to function in two important signaling pathways, serving to regulate both poly-ADP-ribose and O-acetyl-ADP-ribose levels. More

Use of LCAT to Reduce Cholesterol and Prevent Atherosclerosis

A method of decreasing accumulation of cholesterol in arteries of humans by administering lecithin-cholesterol acyltransferase (LCAT). More

Displaying 1..10 of 41 - per page Next page
Order by

Your selection

Therapeutic target: Cardiovascular del; Vascular del

Browse By

Industry sector: Animal health; Biotechnology; Diagnostic; Drug delivery; Drug discovery; Medical device; Pharmaceutical; Research tools
Therapeutic target: Angiogenesis; Atherosclerosis; Hypertension; Hypotension; Ischemia
Development phase: Early Stage; Preclinical; Phase I; Phase I/II; Phase II; Phase III; Phase III/IV; Preregistration; Registered

Products:	Partnering Search	Company Profiling	Deal Negotiation	PL Intelligence	Reports	Comparision
In-licensing:	Latest records	Industry Sector	Therapeutic Target	Search	Profile your company	Pharma partnering
Out-licensing:	Latest records	Industry Sector	Therapeutic Target	Search	Profile your company	Pharma partnering
Companies:	Profiled companies	Industry Sector	Therapeutic Target	Geographic Location	Search	Add your company
Reports:	Biotechnology	Business Development	Management	Market & Sales	Medical Devices	Pharmaceuticals
Jobs:	Pharmaceutical jobs	Browse jobs	Search for jobs	Create your CV	Employer profiles	Post your jobs
Forums:	Talk to an expert	Industry Gossip	Business Development	What's new	Reports	Services
News:	Deals & Alliances	Development	Financial Results	Financings	Intellectual Property	Regulatory
Events:	Pharma events	Calendar	Organizers	Featured events	Search
Articles:	Business Development	Technologies	Events	Legal and regulatory	Therapeutic
Deals:	Industry Sector	Therapeutic Target	Deals Date	Search	Reports	Press releases
About us:	Our Audience	Case Studies	Newsletter	Careers	FAQ	Contact us